Blinatumomab Bridging Therapy
Conditions: B-cell Acute Lymphoblastic Leukemia; Refractory B Acute Lymphoblastic Leukemia; Relapsed B-cell Acute Lymphoblastic Leukemia Intervention: Drug: Blinatumomab Sponsors: Michael Burke; Amgen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials